期刊文献+

纤维蛋白原是2型糖尿病尿蛋白进展的预测指标 被引量:15

Fibrinogen is a predictor for progressive proteinuria in type 2 diabetes
原文传递
导出
摘要 回顾性分析2型糖尿病患者尿蛋白进展与凝血功能的关系。发现随着微量白蛋白尿的逐级增加,纤维蛋门原(FIB)明显增加,FIB是微量白蛋白尿升高的独立危险因素。且早期肾病进展至临床肾病组的基线FIB较非进展组升高[(3.5±0.9对3.0±0.6)g/L,P〈O.05]。FIB或可作为2型糖尿病尿蛋白进展的预测指标。 The association of coagulation function with progressive proteinuria in type 2 diabetic patients wasretrospectively analyzed. With increasing microalbuminuria, fibrinogen level was increased significantly. Fibrinogen was an independent risk factor of microalbuminuria. In patients as the early-stage diabetic nephropathy ( DN ) progressed to clinical-stage DN, the baseline level of fibrinogen was also increased [ ( 3.5 ±0.9 vs 3.0±0. 6 ) g/L, P〈0.05 ]. Fibrinogen may serve as a useful predictor of progressive proteinuria in type 2 diabetes.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第9期726-728,共3页 Chinese Journal of Endocrinology and Metabolism
基金 围家自然科学基金项目(81072922,81173428)
关键词 糖尿病 2型 糖尿病肾病 凝血 蛋白尿 纤维蛋白原 Diabetes mellitus type 2 Diabetic nephropathies Coagulation Proteinuria Fibrinogen
  • 相关文献

参考文献8

  • 1Parving HH, Oxenboll B, Svendsen PA, et al. Early detection of patients at risk of developing diabetic nephropathy: A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh), 1982,100:550-555.
  • 2Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine:a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 1999,130:461-470.
  • 3Madan R, Gupt B, Saluja S,et al. Coagulation profile in diabetes and its association with diabetic microvascular complications. J Assoc Physicians India, 2010,58:481-484.
  • 4Casserly LF, Dember LM. Thrombosis in end-stage renal disease. Semin Dial, 2003,16:245-256.
  • 5Klein RL, Hunter SJ, Jenkins AJ, et al. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care, 2003,26,1439-1448.
  • 6Bruno G, Merletti F, Biggeri A, et al. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study. Diabetes Care, 2003,26:2150-2155.
  • 7Li J, Wu HM, Zhang L, et al. Heparin and related substances for preventing diabetic kidney disease. Cochrane Database Syst Rev, 2010,9:CD005631.
  • 8Blouza S, Dakhli S, Abid H, et al. Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy. J Nephrol, 2010,23:415-424.

同被引文献112

引证文献15

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部